About
Mitotherapeutix develops siRNA-based drugs targeting a novel mitochondrial protein that regulates metabolic efficiency, aiming to treat diseases by increasing cellular metabolism.
Explore Mitotherapeutix LLC's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.